ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
New Kid on the Block Trifarotene: fourth-generation topical retinoid
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 199930" data-attributes="member: 13851"><p><strong>Figure 1. Graphic abstract representing the current applications of trifarotene in dermatological clinical trials and molecular pathways. In the left section, the action of trifarotene in acne is reported. It performs both immunoregulatory—leading to an increase in the expression of transforming growth factor-β and interleukin-4—and keratoplastic functions, increasing the expression of keratins K1, K5, K10, K14, and K16. Moreover, it seems that trifarotene, like other retinoids, may have a role in modulating skin microbiota. Finally, trifarotene weakens hemidesmosomes, interfering with cell adhesion. The migration of keratinocytes, caused by the drug, mediates its comedolytic property. The importance of trifarotene in lamellar ichthyosis has been reported in the central section. Trifarotene, by means of RAR-γ, causes an increased expression of transglutaminase 1, promoting keratinocyte cohesion. The rationale for the use of trifarotene in cutaneous T cell lymphomas has been reported in the right section. It seems to promote apoptosis and differentiation, upregulating caspases 3 and 8, p21 and p27</strong></p><p><strong>[ATTACH=full]13844[/ATTACH]</strong></p></blockquote><p></p>
[QUOTE="madman, post: 199930, member: 13851"] [B]Figure 1. Graphic abstract representing the current applications of trifarotene in dermatological clinical trials and molecular pathways. In the left section, the action of trifarotene in acne is reported. It performs both immunoregulatory—leading to an increase in the expression of transforming growth factor-β and interleukin-4—and keratoplastic functions, increasing the expression of keratins K1, K5, K10, K14, and K16. Moreover, it seems that trifarotene, like other retinoids, may have a role in modulating skin microbiota. Finally, trifarotene weakens hemidesmosomes, interfering with cell adhesion. The migration of keratinocytes, caused by the drug, mediates its comedolytic property. The importance of trifarotene in lamellar ichthyosis has been reported in the central section. Trifarotene, by means of RAR-γ, causes an increased expression of transglutaminase 1, promoting keratinocyte cohesion. The rationale for the use of trifarotene in cutaneous T cell lymphomas has been reported in the right section. It seems to promote apoptosis and differentiation, upregulating caspases 3 and 8, p21 and p27 [ATTACH type="full"]13844[/ATTACH][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
New Kid on the Block Trifarotene: fourth-generation topical retinoid
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top